Breaking News Instant updates and real-time market news.

A

Agilent

$75.98

2.13 (2.88%)

07:30
05/15/19
05/15
07:30
05/15/19
07:30

Agilent removed from Analyst Focus List at JPMorgan

JPMorgan analyst Tycho Peterson removed Agilent Technologies from his firm's Analyst Focus List following the company's fiscal Q2 results but keeps an Overweight rating on the shares with an $85 price target. Agilent reported a "surprising miss," with core growth of 4% below guidance of 5%-6% despite the easy 4.3% comp and generally solid Q1 peer results, Peterson tells investors in a research note. He attributes the miss to worse than expected headwinds from China generic pharma and food, as well as global large pharma order delays on the small-molecule side. While the miss and guidance cut were "clearly disappointing," the weakness appears driven by end market headwinds rather than competitive dynamics, and Agilent's margin expansion remains strong despite sales headwinds, says Peterson. He continues to like the stock's risk/reward at current valuation levels.

  • 31

    May

A Agilent
$75.98

2.13 (2.88%)

02/21/19
DBAB
02/21/19
NO CHANGE
Target $90
DBAB
Buy
Agilent price target raised to $90 from $85 at Deutsche Bank
Deutsche Bank analyst Dan Leonard raised his price target for Agilent Technologies to $90 and reiterates a Buy rating on the shares following the company's fiscal Q1 results and a fiscal 2019 earnings guidance increase. The analyst continues to believe Agilent has more opportunities for growth, margin expansion, and capital deployment than peers.
02/21/19
BARD
02/21/19
NO CHANGE
Target $82
BARD
Outperform
Agilent price target raised to $82 from $77 at Baird
Baird analyst Catherin Ramsey-Schulte raised her price target on Agilent to $82 from $77 following Q4 results. The analyst said the shares may be weak following the report given the stock's recent run up and the weakness in LSAG growth. She believes the underlying business remains healthy and continues to see upside from end market strength, new product introductions, and potential incremental capital deployment. Ramsey-Schulte reiterated her Outperform rating on Agilent shares.
03/15/19
UBSW
03/15/19
INITIATION
Target $92
UBSW
Buy
Agilent initiated with a Buy at UBS
UBS analyst Daniel Brennan started Agilent Technologies with a Buy rating and $92 price target. The analyst says stronger revenue growth coupled with rising incremental margins support his earnings forecasts being 2%-3% ahead of consensus. Further, "more aggressive" acquisition activity or share buybacks could drive "material further" earnings upside, Brennan tells investors in a research note. He believes Agilent has "significant balance sheet optionality."
03/26/19
COWN
03/26/19
NO CHANGE
Target $90
COWN
Outperform
Agilent price target raised to $90 from $80 at Cowen
Cowen analyst Doug Schenkel maintained an Outperform rating on Agilent and raised his price target to $90 from $80 after hosting meetings with management. In a research note to investors, Schenkel says he came away from the meetings with incremental confidence in the company's ability to continue posting above-peer average top and bottom line growth in the near- and long-term. He believes shares are worth $(0, and could see further upside as management continues to execute relative to expectations.

TODAY'S FREE FLY STORIES

UPS

UPS

$97.22

-2.47 (-2.48%)

, FDX

FedEx

$156.36

-4.52 (-2.81%)

13:28
06/25/19
06/25
13:28
06/25/19
13:28
Periodicals
UPS says won't join FedEx's suit against U.S., Reuters says »

UPS (UPS) said it does…

UPS

UPS

$97.22

-2.47 (-2.48%)

FDX

FedEx

$156.36

-4.52 (-2.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

  • 30

    Jul

  • 31

    Jul

  • 13

    Nov

EOLS

Evolus

$14.26

0.57 (4.16%)

, AGN

Allergan

$164.07

34.42 (26.55%)

13:26
06/25/19
06/25
13:26
06/25/19
13:26
Recommendations
Evolus, Allergan, AbbVie, Revance, Aerie Pharmaceuticals, TherapeuticsMD, Kala Pharmaceuticals analyst commentary  »

Evolus can benefit from…

EOLS

Evolus

$14.26

0.57 (4.16%)

AGN

Allergan

$164.07

34.42 (26.55%)

ABBV

AbbVie

$66.52

-11.89 (-15.16%)

RVNC

Revance

$12.15

0.59 (5.10%)

AERI

Aerie Pharmaceuticals

$30.34

0.13 (0.43%)

TXMD

TherapeuticsMD

$2.58

0.06 (2.38%)

KALA

Kala Pharmaceuticals

$5.78

0.2 (3.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 10

    Jul

  • 10

    Jul

  • 11

    Jul

  • 11

    Jul

  • 31

    Jul

  • 01

    Aug

  • 15

    Aug

  • 16

    Sep

TDG

TransDigm

$490.64

-0.47 (-0.10%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Hot Stocks
DoD: TransDigm 'negotiating excessive profits' on contracts for spare parts »

The Department of Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$82.69

1.85 (2.29%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:25
06/25/19
06/25
13:25
06/25/19
13:25
General news
Fed Chair Powell repeated the phrase from the FOMC that the Fed is "closely monitoring »

Fed Chair Powell repeated…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

, ETFC

E-Trade

$44.43

-0.14 (-0.31%)

13:25
06/25/19
06/25
13:25
06/25/19
13:25
Conference/Events
Sandler O'Neill financial analyst to hold an analyst/industry conference call »

Financial Analyst Repetto…

IBKR

Interactive Brokers

$52.66

0.21 (0.40%)

ETFC

E-Trade

$44.43

-0.14 (-0.31%)

SCHW

Charles Schwab

$39.22

0.07 (0.18%)

AMTD

TD Ameritrade

$48.32

0.23 (0.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 23

    Jul

  • 06

    Aug

  • 27

    Oct

13:20
06/25/19
06/25
13:20
06/25/19
13:20
General news
FX Action: The DXY rallied »

FX Action: The DXY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
06/25/19
06/25
13:17
06/25/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
06/25/19
06/25
13:16
06/25/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUYA

Huya

$23.90

-1.52 (-5.98%)

13:15
06/25/19
06/25
13:15
06/25/19
13:15
Options
HUYA put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
06/25/19
06/25
13:15
06/25/19
13:15
General news
Treasury's $40 B 2-year auction was mixed as a confluence of factors impacted »

Treasury's $40 B…

ASOMY

Asos

$0.00

(0.00%)

13:11
06/25/19
06/25
13:11
06/25/19
13:11
Downgrade
Asos rating change  »

Asos downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$33.46

0.28 (0.84%)

13:08
06/25/19
06/25
13:08
06/25/19
13:08
On The Fly
Fly Intel: What to watch in Micron's earnings report »

Micron (MU) is scheduled…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 09

    Jul

13:08
06/25/19
06/25
13:08
06/25/19
13:08
General news
2-Yr Note Auction Coupon Rate data reported »

2-Yr Note Auction Coupon…

13:07
06/25/19
06/25
13:07
06/25/19
13:07
General news
2-Yr Note Auction Total Amount data reported »

2-Yr Note Auction Total…

MDR

McDermott

$8.82

0.6 (7.30%)

13:05
06/25/19
06/25
13:05
06/25/19
13:05
Options
McDermott call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORCL

Oracle

$56.48

-0.24 (-0.42%)

13:03
06/25/19
06/25
13:03
06/25/19
13:03
Hot Stocks
Oracle announces 'simplified' analytics product offering »

Oracle said in a press…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLF

Herbalife Nutrition

$43.03

0.82 (1.94%)

12:55
06/25/19
06/25
12:55
06/25/19
12:55
Options
Herbalife put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:55
06/25/19
06/25
12:55
06/25/19
12:55
General news
Fed dove, and dissenter Bullard doesn't believe a 50 bp easing is necessary right now »

Fed dove, and dissenter…

AGN

Allergan

$163.79

34.14 (26.33%)

, ABBV

AbbVie

$66.51

-11.905 (-15.18%)

12:50
06/25/19
06/25
12:50
06/25/19
12:50
Upgrade
Allergan, AbbVie rating change at Barclays »

Allergan upgraded to…

AGN

Allergan

$163.79

34.14 (26.33%)

ABBV

AbbVie

$66.51

-11.905 (-15.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 16

    Sep

AG

First Majestic

$7.98

-0.04 (-0.50%)

12:45
06/25/19
06/25
12:45
06/25/19
12:45
Options
First Majestic call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
06/25/19
06/25
12:45
06/25/19
12:45
General news
Breaking General news story  »

Federal Reserve Chairman…

DIS

Disney

$139.71

0.49 (0.35%)

12:42
06/25/19
06/25
12:42
06/25/19
12:42
Periodicals
MNC founder says not in talks with Disney over investment, Reuters says »

Media Nusantara Citra is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

APVO

Aptevo Therapeutics

$0.90

-0.0445 (-4.71%)

12:38
06/25/19
06/25
12:38
06/25/19
12:38
Recommendations
Aptevo Therapeutics analyst commentary  »

Aptevo IXINITY…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TDOC

Teladoc

$62.00

-0.76 (-1.21%)

12:37
06/25/19
06/25
12:37
06/25/19
12:37
Recommendations
Teladoc analyst commentary  »

Teladoc CFO hiring news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.